Detalhe da pesquisa
1.
The prolyl peptidases PRCP/PREP regulate IRS-1 stability critical for rapamycin-induced feedback activation of PI3K and AKT.
J Biol Chem
; 289(31): 21694-705, 2014 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24936056
2.
Prolylcarboxypeptidase regulates proliferation, autophagy, and resistance to 4-hydroxytamoxifen-induced cytotoxicity in estrogen receptor-positive breast cancer cells.
J Biol Chem
; 286(4): 2864-76, 2011 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-21087932
3.
Methylation patterns in cell-free plasma DNA reflect removal of the primary tumor and drug treatment of breast cancer patients.
Int J Cancer
; 128(2): 492-9, 2011 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20473856
4.
Prolyl endopeptidase inhibitor Y-29794 blocks the IRS1-AKT-mTORC1 pathway and inhibits survival and in vivo tumor growth of triple-negative breast cancer.
Cancer Biol Ther
; 21(11): 1033-1040, 2020 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33044914
5.
Methylation profile of circulating plasma DNA in patients with pancreatic cancer.
J Surg Oncol
; 99(2): 119-22, 2009 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19065635
6.
Biomarkers for early detection of breast cancer: what, when, and where?
Biochim Biophys Acta
; 1770(6): 847-56, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17368950
7.
Array-based multiplex analysis of DNA methylation in breast cancer tissues.
J Mol Diagn
; 10(1): 93-101, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18165279
8.
DNA methylation biomarkers of cancer: moving toward clinical application.
Pharmacogenomics
; 5(6): 699-707, 2004 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-15335290
9.
Critical roles for nitric oxide and ERK in the completion of prosurvival autophagy in 4OHTAM-treated estrogen receptor-positive breast cancer cells.
Cancer Lett
; 353(2): 290-300, 2014 Oct 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-25069039
10.
DNA methylation as clinically useful biomarkers-light at the end of the tunnel.
Pharmaceuticals (Basel)
; 5(1): 94-113, 2012 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-24288045
11.
Methylation of death-associated protein kinase is associated with cetuximab and erlotinib resistance.
Cell Cycle
; 11(8): 1656-63, 2012 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22487682
12.
The MethDet: a technology for biomarker development.
Expert Rev Mol Diagn
; 11(8): 807-12, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22022943
13.
DNA methylation as a universal biomarker.
Expert Rev Mol Diagn
; 10(4): 481-8, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20465502
14.
Biomarkers: diagnostic highlights and surrogate end points. Cambridge Healthtech Institute's biomarker series: biomarker validation: bringing discovery to the clinic & cancer biomarkers: from discovery to clinical practice. May 3-5, 2004, Philadelphia, Pennsylvania, USA.
Pharmacogenomics
; 5(5): 459-61, 2004 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-15212582
15.
Molecular biomarkers in 2013.
Expert Rev Mol Diagn
; 13(8): 773-6, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24151845